RAFAEL HOLDINGS, INC. Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable
RAFAEL HOLDINGS, INC. (RFL) reported Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable of -$34.41 million for the 12-month period ending 2024-07-31, per its 10-K/A filed 2024-12-20.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable · last filed 2024-12-20
- RAFAEL HOLDINGS, INC. noncontrolling interest in net income (loss) other noncontrolling interests, redeemable for the quarter ending 2024-07-31 was -$4.47M, a 447.98% decline year-over-year.
- RAFAEL HOLDINGS, INC. noncontrolling interest in net income (loss) other noncontrolling interests, redeemable for the quarter ending 2024-04-30 was -$32.35M.
- RAFAEL HOLDINGS, INC. noncontrolling interest in net income (loss) other noncontrolling interests, redeemable for the quarter ending 2024-01-31 was $6.05M.
- RAFAEL HOLDINGS, INC. noncontrolling interest in net income (loss) other noncontrolling interests, redeemable for the quarter ending 2023-10-31 was -$3.64M.
- RAFAEL HOLDINGS, INC. noncontrolling interest in net income (loss) other noncontrolling interests, redeemable for fiscal 2024 was -$34.41M.
- RAFAEL HOLDINGS, INC. noncontrolling interest in net income (loss) other noncontrolling interests, redeemable for fiscal 2023 was -$8.35M.
- RAFAEL HOLDINGS, INC. noncontrolling interest in net income (loss) other noncontrolling interests, redeemable for fiscal 2022 was -$122.83M.
| Period end | Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable 3 month | Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable 3 month as first filed | Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable 6 month | Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable 6 month as first filed | Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable 9 month | Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable 9 month as first filed | Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable 12 month |
|---|---|---|---|---|---|---|---|
| 2024-07-31 | -$4.47M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-20 | -$36.82M derived: sum of 2 quarters · filed 2024-12-20 | -$30.77M derived: sum of 3 quarters · filed 2024-12-20 | -$34.41M 10-K/A · filed 2024-12-20 | |||
| 2024-04-30 | -$32.35M 10-Q · filed 2024-06-14 | -$26.30M derived: sum of 2 quarters · filed 2024-06-14 | -$29.94M 10-Q · filed 2024-06-14 | -$28.66M derived: sum of 4 quarters · filed 2024-12-20 | |||
| 2024-01-31 | $6.05M 10-Q · filed 2024-03-14 | $2.41M 10-Q · filed 2024-03-14 | $3.69M derived: sum of 3 quarters · filed 2024-12-20 | $2.26M derived: sum of 4 quarters · filed 2024-12-20 | |||
| 2023-10-31 | -$3.64M 10-Q · filed 2023-12-14 | -$2.35M derived: sum of 2 quarters · filed 2024-12-20 | -$3.79M derived: sum of 3 quarters · filed 2024-12-20 | -$6.88M derived: sum of 4 quarters · filed 2024-12-20 | |||
| 2023-07-31 | $1.28M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-20 | -$153.00K derived: sum of 2 quarters · filed 2024-12-20 | -$3.25M derived: sum of 3 quarters · filed 2024-12-20 | -$8.35M 10-K/A · filed 2024-12-20 | |||
| 2023-04-30 | -$1.44M 10-Q · filed 2024-06-14 | -$53.00K 10-Q · filed 2023-06-13 | -$4.53M derived: sum of 2 quarters · filed 2024-06-14 | -$9.64M 10-Q · filed 2024-06-14 | -$311.00K 10-Q · filed 2023-06-13 | -$114.82M derived: sum of 4 quarters · filed 2024-06-14 | |
| 2023-01-31 | -$3.09M 10-Q · filed 2024-03-14 | -$159.00K 10-Q · filed 2023-03-14 | -$8.20M 10-Q · filed 2024-03-14 | -$258.00K 10-Q · filed 2023-03-14 | -$113.38M derived: sum of 3 quarters · filed 2024-03-14 | -$113.40M derived: sum of 4 quarters · filed 2024-03-14 | |
| 2022-10-31 | -$5.11M 10-Q · filed 2023-12-14 | -$99.00K 10-Q · filed 2022-12-13 | -$110.29M derived: sum of 2 quarters · filed 2023-12-14 | -$110.31M derived: sum of 3 quarters · filed 2023-12-14 | -$110.55M derived: sum of 4 quarters · filed 2023-12-14 | ||
| 2022-07-31 | -$105.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-30 | -$105.20M derived: sum of 2 quarters · filed 2023-10-30 | -$105.44M derived: sum of 3 quarters · filed 2023-10-30 | -$122.83M 10-K · filed 2023-10-30 | |||
| 2022-04-30 | -$19.00K 10-Q · filed 2023-06-13 | -$263.00K derived: sum of 2 quarters · filed 2023-06-13 | -$17.65M 10-Q · filed 2023-06-13 | ||||
| 2022-01-31 | -$244.00K 10-Q · filed 2023-03-14 | -$17.63M 10-Q · filed 2023-03-14 | |||||
| 2021-10-31 | -$17.39M 10-Q · filed 2022-12-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |